188 related articles for article (PubMed ID: 31131058)
21. Rapid visual identification of PCR amplified nucleic acids by centrifugal gel separation: Potential use for molecular point-of-care tests.
Hwang SH; Kim DE; Im JH; Kang SJ; Lee DH; Son SJ
Biosens Bioelectron; 2016 May; 79():829-34. PubMed ID: 26774997
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
[TBL] [Abstract][Full Text] [Related]
23. Testing and genotyping of high-risk human papillomavirus by the cobas HPV Test and the Hybrid Capture 2 high-risk HPV DNA test using cervical and vaginal samples.
Pyne MT; Law C; Hillyard DR; Schlaberg R
J Clin Microbiol; 2014 May; 52(5):1720-3. PubMed ID: 24554756
[TBL] [Abstract][Full Text] [Related]
24. Electrochemical chip-based genomagnetic assay for detection of high-risk human papillomavirus DNA.
Bartosik M; Durikova H; Vojtesek B; Anton M; Jandakova E; Hrstka R
Biosens Bioelectron; 2016 Sep; 83():300-5. PubMed ID: 27132004
[TBL] [Abstract][Full Text] [Related]
25. 3D-printed Point-of-Care Platform for Genetic Testing of Infectious Diseases Directly in Human Samples Using Acoustic Sensors and a Smartphone.
Papadakis G; Pantazis AK; Ntogka M; Parasyris K; Theodosi GI; Kaprou G; Gizeli E
ACS Sens; 2019 May; 4(5):1329-1336. PubMed ID: 30964650
[TBL] [Abstract][Full Text] [Related]
26. The evaluation of loop-mediated isothermal amplification-quartz crystal microbalance (LAMP-QCM) biosensor as a real-time measurement of HPV16 DNA.
Jearanaikoon P; Prakrankamanant P; Leelayuwat C; Wanram S; Limpaiboon T; Promptmas C
J Virol Methods; 2016 Mar; 229():8-11. PubMed ID: 26695714
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the analytical and clinical performances of Abbott RealTime High Risk HPV, Hybrid Capture 2, and DNA Chip assays in gynecology patients.
Park S; Kang Y; Kim DG; Kim EC; Park SS; Seong MW
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):432-6. PubMed ID: 23791386
[TBL] [Abstract][Full Text] [Related]
28. Nested multiplex PCR based detection of human papillomavirus in cervical carcinoma patients of North- East India.
Das D; Rai AK; Kataki AC; Barmon D; Deka P; Sharma JD; Sarma A; Shrivastava S; Bhattacharyya M; Kalita AK; Sharma M; Ahmed S
Asian Pac J Cancer Prev; 2013; 14(2):785-90. PubMed ID: 23621238
[TBL] [Abstract][Full Text] [Related]
29. Potential coverage of circulating HPV types by current and developing vaccines in a group of women in Bosnia and Herzegovina with abnormal Pap smears.
Salimović-Bešić I; Hukić M
Epidemiol Infect; 2015 Sep; 143(12):2604-12. PubMed ID: 25578155
[TBL] [Abstract][Full Text] [Related]
30. Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR.
van Doorn LJ; Molijn A; Kleter B; Quint W; Colau B
J Clin Microbiol; 2006 Sep; 44(9):3292-8. PubMed ID: 16954263
[TBL] [Abstract][Full Text] [Related]
31. Multiplex polymerase chain reaction for the detection of high-risk-human papillomavirus types in formalin-fixed paraffin-embedded cervical tissues.
Singh MP; Gupta N; Deepak T; Kumar A; Ratho RK
Indian J Med Microbiol; 2017; 35(1):113-115. PubMed ID: 28303830
[TBL] [Abstract][Full Text] [Related]
32. An evaluation of clinical performance of FTA cards for HPV 16/18 detection using cobas 4800 HPV Test compared to dry swab and liquid medium.
Dong L; Lin C; Li L; Wang M; Cui J; Feng R; Liu B; Wu Z; Lian J; Liao G; Chen W; Qiao Y
J Clin Virol; 2017 Sep; 94():67-71. PubMed ID: 28763729
[TBL] [Abstract][Full Text] [Related]
33. Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development.
Winer RL; Harris TG; Xi LF; Jansen KU; Hughes JP; Feng Q; Welebob C; Ho J; Lee SK; Carter JJ; Galloway DA; Kiviat NB; Koutsky LA
J Med Virol; 2009 Apr; 81(4):713-21. PubMed ID: 19235870
[TBL] [Abstract][Full Text] [Related]
34. The Abbott RealTime High Risk HPV test: comparative evaluation of analytical specificity and clinical sensitivity for cervical carcinoma and CIN 3 lesions with the Hybrid Capture 2 HPV DNA test.
Poljak M; Kovanda A; Kocjan BJ; Seme K; Jancar N; Vrtacnik-Bokal E
Acta Dermatovenerol Alp Pannonica Adriat; 2009 Sep; 18(3):94-103. PubMed ID: 19784522
[TBL] [Abstract][Full Text] [Related]
35. An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings.
Kundrod KA; Barra M; Wilkinson A; Smith CA; Natoli ME; Chang MM; Coole JB; Santhanaraj A; Lorenzoni C; Mavume C; Atif H; Montealegre JR; Scheurer ME; Castle PE; Schmeler KM; Richards-Kortum RR
Sci Transl Med; 2023 Jun; 15(701):eabn4768. PubMed ID: 37343083
[TBL] [Abstract][Full Text] [Related]
36. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
[No Abstract] [Full Text] [Related]
37. Analytical performance of Cervista HPV 16/18 genotyping test for cervical cytology samples.
Bartholomew DA; Luff RD; Quigley NB; Curtis M; Olson MC
J Clin Virol; 2011 May; 51(1):38-43. PubMed ID: 21376660
[TBL] [Abstract][Full Text] [Related]
38. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
[TBL] [Abstract][Full Text] [Related]
39. Α 2-stage, nested-like nucleic acid amplification method (IsoPCR) for the highly sensitive detection of HPV16 and HPV18 DNA.
Daskou M; Tsakogiannis D; Dimitriou TG; Manali M; Apti C; Amoutzias GD; Mossialos D; Kottaridi C; Markoulatos P
Mol Cell Probes; 2019 Jun; 45():1-7. PubMed ID: 30902662
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples.
Munoz M; Camargo M; Soto-De Leon SC; Sanchez R; Parra D; Pineda AC; Sussmann O; Perez-Prados A; Patarroyo ME; Patarroyo MA
PLoS One; 2013; 8(2):e56509. PubMed ID: 23418581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
